What Is Zurzuvae? Uses, Dosage, and What You Need to Know in 2026

Zurzuvae (zuranolone) is a prescription medication that made medical history in August 2023 when the FDA approved it as the first and only oral treatment specifically for postpartum depression (PPD) in adults. It represents a fundamentally different class of antidepressant—one that works through the brain's GABA system rather than the serotonin pathway targeted by traditional SSRIs.

Here's everything you need to know about Zurzuvae in plain language.

What Is Zurzuvae Used For?

Zurzuvae has one FDA-approved indication: the treatment of

postpartum depression (PPD) in adults.

Postpartum depression is a major depressive episode that typically occurs after childbirth, though it can also begin during the later stages of pregnancy. PPD affects an estimated 10–15% of new mothers in developed countries and can range from mild-to-moderate sadness and anxiety to severe symptoms including suicidal thoughts and inability to care for the baby.

The FDA approval of Zurzuvae specifically covers PPD in adults whose symptoms begin in the third trimester or within four weeks of delivery. ACOG also recommends consideration of Zurzuvae within 12 months of delivery for severe cases.

Note: The FDA issued a Complete Response Letter (rejecting approval) for Zurzuvae in major depressive disorder (MDD) in August 2023, citing insufficient evidence of effectiveness for that indication.

What Drug Class Is Zurzuvae?

Zurzuvae belongs to a new class called

neuroactive steroids (NAS)—more specifically, it's a GABA-A receptor positive allosteric modulator (PAM). This is different from SSRIs and SNRIs, which work on the serotonin system. Zurzuvae works on the brain's GABA system—the primary inhibitory (calming) signaling pathway.

What Is the Dosage of Zurzuvae?

Zurzuvae comes as oral capsules in three strengths: 20 mg, 25 mg, and 30 mg.

• Recommended adult dose: 50 mg once daily in the evening (typically two 25 mg capsules)
• Treatment duration: 14 days (one continuous course)
• When to take: Evening, with a fatty meal (food significantly increases absorption—Zurzuvae should not be taken on an empty stomach)
• Driving restriction: Do not drive or operate heavy machinery for at least 12 hours after each dose throughout the 14-day course

Dose reductions may be required for patients on strong CYP3A4 inhibitors or those with severe hepatic impairment.

How Quickly Does Zurzuvae Work?

This is one of Zurzuvae's most important differentiators. In the SKYLARK Phase 3 trial, patients showed statistically significant improvement in depressive symptoms as early as

Day 3. The primary clinical endpoint—a significant reduction on the 17-item Hamilton Depression Rating Scale (HAMD-17)—was measured at Day 15, and benefits were sustained through Day 45.

In comparison, traditional SSRIs typically take 2–4 weeks to show meaningful antidepressant effects.

39,049+ patients found their medications in stock

39K+

Find Zurzuvae In Stock Today →

Who Makes Zurzuvae?

Zurzuvae was developed by Sage Therapeutics and is co-commercialized with Biogen. Sage Therapeutics pioneered the neuroactive steroid (NAS) drug class, which also included brexanolone (Zulresso)—now withdrawn from the market as of January 2025. Sage Central (1-844-987-9882) is the manufacturer's patient support program.

Where Is Zurzuvae Available?

Zurzuvae is only available through authorized specialty pharmacies—not at retail locations like CVS or Walgreens. It is dispensed by mail and is not available as a walk-in pickup. It became commercially available in December 2023.

Skip the calls, skip the stress.

Find Zurzuvae In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Is Zurzuvae a Controlled Substance?

Yes. Zurzuvae is classified as a

Schedule IV (C-IV) controlled substance by the DEA. This means it has recognized potential for abuse, misuse, and physical dependence—similar to medications like alprazolam (Xanax). Any provider with DEA prescribing authority can prescribe it.

How Much Does Zurzuvae Cost?

The wholesale list price is approximately $15,900 for a 14-day treatment course. Most patients with commercial insurance can access the medication with a reduced copay, and the Zurzuvae Savings Card can bring costs to $0 for eligible commercially insured patients. Uninsured patients may qualify for a free drug program through Sage Therapeutics.

How to Get Zurzuvae

Getting Zurzuvae requires: (1) a prescription from a licensed provider with DEA authority, (2) routing the prescription to an authorized specialty pharmacy, and (3) navigating prior authorization if required by your insurance. medfinder can help you find which specialty pharmacies can fill your prescription. See our full access guide: How to Find Zurzuvae In Stock Near You.